Evidence map›Paper›PMID 40188253›Full record

ArticleScientific reports2025

Sex-specific aspects in a population of patients undergoing evaluation for interstitial lung disease with transbronchial cryobiopsy.

Janna Reinhard, Markus Polke, Katharina Buschulte, Monika Eichinger, Claus Peter Heußel, Maximilian Güttlein, Julia D Michels-Zetsche, Mark Oliver Wielpütz, Kathrin Kahnert, Konstantina Kontogianni and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Janna Reinhard *Department of Pneumology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Thoraxklinik University of Heidelberg, Heidelberg, Germany.
Markus Polke *Department of Pneumology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Thoraxklinik University of Heidelberg, Heidelberg, Germany.
Katharina BuschulteDepartment of Pneumology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Thoraxklinik University of Heidelberg, Heidelberg, Germany.
Monika EichingerTranslational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.
Claus Peter HeußelTranslational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.
Maximilian GüttleinTranslational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.
Julia D Michels-ZetscheDepartment of Pneumology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Thoraxklinik University of Heidelberg, Heidelberg, Germany.
Mark Oliver WielpützTranslational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.
Kathrin KahnertMediCenterGermering, Germering, Germany.
Konstantina KontogianniDepartment of Pneumology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Thoraxklinik University of Heidelberg, Heidelberg, Germany.
Laura V KlotzTranslational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.
Michael AllgäuerDepartment of Pathology, University of Heidelberg, Heidelberg, Germany.
Felix J HerthDepartment of Pneumology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Thoraxklinik University of Heidelberg, Heidelberg, Germany.
Ralf EberhardtDepartment of Pneumology and Intensive Care Medicine, Asklepios Klinik Barmbek, Hamburg, Germany.
Michael KreuterDepartments of Pneumology, Mainz Center for Pulmonary Medicine, Mainz University Medical Center and of Pulmonary, Critical Care & Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.
Franziska C TrudzinskiDepartment of Pneumology and Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Thoraxklinik University of Heidelberg, Heidelberg, Germany. franziska.trudzinski@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are well-documented differences in idiopathic pulmonary fibrosis (IPF) between sexes. The sex-specific prevalence of interstitial lung disease (ILD) subtypes in patients who require a full diagnostic work-up, including transbronchial cryobiopsy (TCB), after initial multidisciplinary discussion (MDD) is still unknown. Retrospective analysis of sex dispareties in patients with ILD who received an interdisciplinary indication for lung biopsy and underwent bronchoalveolar lavage, TCB and, if necessary, surgical lung biopsy at our ILD centre in Heidelberg between 11/17 and 12/21. The analysis included clinical parameters, visual assessment of computed tomography (CT), automated histogram analyses of lung density by validated software and final MDD-ILD classifications. A total of 402 patients (248 men, 154 women; mean age 68 ± 12 years) were analysed. Smoking behaviour was similar between the sexes, but women were more exposed to environmental factors, whereas men were more exposed to occupational factors. Women had higher rates of thyroid disease (29.9% vs. 12.5%; p < 0.001) and extrathoracic malignancies (16.2% vs. 9.3%; p = 0.041), but lower rates of coronary heart disease (7.1% vs. 19.8%; p < 0.001), stroke (1.3% vs. 6.5%; p = 0.014) and sleep apnoea (5.8% vs. 17.7%; p < 0.001). There were no sex differences regarding CT lung density. On visual inspection, women were less likely to have reticular opacities (65% vs. 76%; p = 0.017) and features of usual interstitial pneumonia (17% vs. 34%; p < 0.001). Among final diagnoses, hypersensitivity pneumonitis was more common in women (34.4%) compared to men (21.8%; p = 0.007). In contrast, IPF was more common in men (22.6%) than in women (7.1%; p < 0.001), and unclassifiable interstitial lung disease was also more frequent in men (21.8%) compared to women (6.5%; p < 0.001). This study highlights significant sex-based differences in the prevalence and characteristics of ILD requiring comprehensive diagnostic work-up. These findings underscore the importance of considering sex-specific factors in the diagnosis and management of ILD.

Indexed as

Lung Diseases, InterstitialAgedAged, 80 and overBiopsyBronchoscopyCryosurgeryFemaleHumansIdiopathic Pulmonary FibrosisLungMaleMiddle AgedRetrospective StudiesSex FactorsTomography, X-Ray ComputedComputed tomographyGenderIdiopathic pulmonary fibrosisInterstitial lung diseaseQuantitative CT analysisSexTransbronchial lung cryobiopsy

Identifiers

PMID40188253
PMCPMC11972388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.